- Global Pharma News & Resources

Rapid Nutrition PLC: Global Brand and Operations Executive Carl Seletz Joins Rapid Nutrition Advisory Board

EQS Group-News: Rapid Nutrition PLC / Key word(s): Personnel
15.03.2021 / 06:00

Global Brand and Operations Executive Carl Seletz Joins Rapid Nutrition Advisory Board

London, UK - Rapid Nutrition PLC (OTCQB: RPNRF, SW: RAP), a natural healthcare company focused on sports nutrition, diet management and life sciences products with extensive worldwide distribution, is pleased to announce that international brand, retail and operations leader Carl Seletz has joined its advisory board.

Seletz most recently served as Chief Global Officer for global health and nutrition provider GNC, where he championed the company's retail, wholesale, distribution, digital, ecommerce and business development functions for the international division, spanning more than 2,100 locations in more than 60 countries. Prior to that, he was GNC's Senior Vice President, International, responsible for business development and managing company-owned and franchise operations for the international enterprise.

"With expertise in the United States and abroad, Carl is a corporate and key opinion leader whose talent and insights will continue to bolster our advisory team, and we are thrilled to welcome him on to the Rapid Nutrition Advisory Board," said Rapid Nutrition CEO Simon St. Ledger.

Seletz has also led retail and wholesale ventures for prominent global retailers including Gap Inc., Abercrombie & Fitch, Victoria's Secret, and Bath & Body Works, among others. He is a graduate of Carnegie Mellon University with a degree in professional writing and communications.

"As Rapid Nutrition continues to work towards expanding its international footprint, I look forward to sharing my global operations experience to further the company's growth," Seletz said.

About Rapid Nutrition
Dedicated to the development and distribution of premium, science-based health and wellness brands across the globe, Rapid Nutrition shares a wealth of award-winning products with consumers who are passionate about innovations that are "made by nature, refined by science." Rapid Nutrition's first-class scientific team matches the experience of its management team to keep both the company and consumers on top of the latest industry trends and developments, while aligning with industry leaders worldwide to deliver effective supplements and solutions. Rapid Nutrition aims to be the supplier of choice globally by offering premium brands with the highest-quality ingredients to deliver maximum results.

For more information, please visit

Investor Relations Contact:

Forward-Looking Statements
This press release contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 that involve risks, uncertainties and assumptions that could cause Rapid Nutrition PLCs actual results and experience to differ materially from anticipated results and expectations expressed in these forward-looking statements. Rapid Nutrition PLC has in some cases identified forward-looking statements by using words such as "anticipates," "believes," "hopes," "estimates," "looks," "expects," "plans," "intends," "goal," "potential," "may," "suggest," and similar expressions. Rapid PLC undertakes no obligation to release publicly the results of any revisions to any such forward-looking statements that may be made to reflect events or circumstances after the date of this press release or to reflect the occurrence of unanticipated events, except as required by applicable law or regulation.

Disclosure Requirement:
This media information does not constitute an offer to sell, or a solicitation of an offer to buy, any securities. This information does not constitute an offering prospectus within the meaning of article 652a or article 1156 of the Swiss Code of Obligations or a listing prospectus within the meaning of the listing rules of the SIX Swiss Exchange. The media release is in accordance with International Reporting Standard: Rule 12g3-2(b) under the Securities Exchange Act ('Rule 12g3-2(b)') permits non-U.S. companies with securities listed primarily on a Qualified Foreign Exchange to make publicly available to U.S investors in English the same information that is made publicly available in their home countries as an alternative to SEC reporting Exchange Act Rule 12g3-2(b).

End of Media Release

Editor Details

Last Updated: 15-Mar-2021